Bixiye
QP19-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Galafold (migalastat)
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2161 - 2170 ee natiijooyinka 3613
Bixiye
QP21-19 Reminder: Blue Cross Vision Plans with the Davis Vision Network
Taariikhda uu dhaqangalayo Barnaamijka: 27, Feb 2019
Bixiye
2019 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2019
Bixiye
QP8-19 Addition of Drugs to the Oral Tetracycline Derivatives Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP12-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Immune Globulins
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP15-19 Online Medical Policy Surveys for Authorizations
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP9-19 Addition of Drugs to existing Prior Authorization with Quantity Limit Programs
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP13-19 Medicare Vaccine Coverage
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP11-19 April is STI/STD Awareness Month
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP10-19 Pharmacy Benefit Exclusion for Dymista, Duexis, Qbrexza, Vimovo, and Yosprala
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019